Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 7/20 | 0.32 |
| ▸ | PIP4K2A | P48426 | 2/20 | 0.32 |
| ▸ | IKBKB | O14920 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | TSPO | P30536 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21378034 | 1.00 | CYP11B2 (0.36) | CYP11B2NPY5RPDE10APIP4K2AIKBKB | |
| SCHEMBL21378018 | 0.94 | CYP11B2 (0.36) | CYP11B2NPY5RPDE10AIKBKBSQOR | |
| SCHEMBL21396891 | 0.94 | CYP11B2 (0.36) | CYP11B2NPY5RPDE10AIKBKBSQOR | |
| SCHEMBL21378045 | 0.94 | CYP11B2 (0.36) | CYP11B2NPY5RPDE10AIKBKBSQOR | |
| SCHEMBL21377946 | 0.91 | TSPO (0.34) | NPY5RKDM4EGAATSPO | |
| SCHEMBL21378065 | 0.90 | CYP11B2 (0.38) | CYP11B2PDE10APIP4K2AIDO1 | |
| SCHEMBL21377930 | 0.90 | CYP11B2 (0.38) | CYP11B2PDE10APIP4K2AIDO1 | |
| SCHEMBL21396865 | 0.86 | CYP11B2 (0.37) | CYP11B2NPY5RPDE10AKDM4EDHODH | |
| SCHEMBL21396871 | 0.86 | CYP11B2 (0.37) | CYP11B2NPY5RPDE10AKDM4EDHODH | |
| SCHEMBL21840854 | 0.86 | CYP11B2 (0.41) | CYP11B2PDE10ASQORKDM4EGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11608333-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2023-03-21 | — | — | US | disclosed |
| US-20190292181-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | Kyulux North America, Inc. | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292181-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, SLCO1B3, NDUFV3 | CYP11B2 1221/4885NPY5R 3165/4885PDE10A 3833/4885 |
| US-11608333-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, SLCO1B3, NDUFV3 | CYP11B2 1221/4885NPY5R 3165/4885PDE10A 3833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.